Shares of Eli Lilly & Co. (LLY) are soaring Tuesday morning on reports of its abemaciclib drug seeing success in a late-stage breast cancer study. The stock has gapped higher and is climbing on heavy volume. Let's check out the charts and indicators to see how much prices could rally.
More from Investing
Soft corporate hardware spending continues weighing on Cisco's top line. Also, the company disclosed CFO Kelly Kramer is retiring.
The growth stocks that have been down three days in a row came roaring back, so let's try to figure this market out.
Both Apple and Tesla are chopping shares into pieces, which will let individual investors have a shot at buying them.
Their current goal is to identify a public, possibly former unicorn, to take a stake.